IXICO plc (AIM:IXI)

London flag London · Delayed Price · Currency is GBP · Price in GBX
6.75
-0.25 (-3.57%)
Apr 28, 2026, 4:12 PM GMT
-25.00%
Market Cap 15.26M
Revenue (ttm) 6.53M
Net Income (ttm) -1.65M
Shares Out 218.05M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 432,292
Average Volume 175,219
Open 6.75
Previous Close 7.00
Day's Range 6.75 - 7.25
52-Week Range 6.75 - 15.00
Beta 0.22
RSI 9.88
Earnings Date May 19, 2026

About IXICO

IXICO plc provides data analytics services to biopharmaceutical industry in the United States, the United Kingdom, the Netherlands, Denmark, Switzerland, Ireland, Europe, and internationally. The company offers collection, analysis, management, and reporting on gathered clinical study data; neurological diseases data collection and analysis; and sales and marketing services. It also provides imaging contract research organization solutions, including imaging biomarkers, such as radiological reads, volumetric MRI, PET and SPECT, and advanced MRI... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1995
Employees 79
Stock Exchange London Stock Exchange AIM
Ticker Symbol IXI
Full Company Profile

Financial Performance

In fiscal year 2025, IXICO's revenue was 6.53 million, an increase of 13.32% compared to the previous year's 5.77 million. Losses were -1.65 million, -17.49% less than in 2024.

Financial Statements

News

There is no news available yet.